Navigation Links
Jiangsu in Medical News

Access Pharmaceuticals Provides Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan

...currently marketed DACH platinum, Eloxatin, which has sales in excess of $2 billion. Access has previously announced that it has licensed ProLindac to jiangsu Aosaikang Pharmaceutical Co., Ltd. ("ASK") for the Greater China Region and to JCOM, Ltd for South Korea. Under these agreements both of these partner...

MIT is pleased to announce that it has signed the Joint Venture agreement with its Chinese partners and has received an initial order of 120 units for Animal vaccination

...venture. The name of the joint venture company is "Jiangsu Hualan MIT Medical Technology (MIT China) Ltd" and will be located in Taizhou city in the jiangsu province. This prime location, supported by the central government, will become the most important medical city in China through the relocation of the...

Chinese Non-Small-Cell Lung Cancer Drug Market Will More Than Double by 2013

...n China also finds that increased penetration of current targeted therapies such as AstraZeneca's Iressa (gefitinib), Roche's Tarceva (erlotinib) and jiangsu Simcere's Endostar (endostatin) and the launch of new targeted therapies -- Roche's Avastin (bevacizumab) and Merck KGaA's Erbitux (cetuximab) -- are ...

Chinese Colorectal Cancer Drug Market Will More Than Double by 2012

...provement in access to medical care and significantly increased prescribing of targeted therapies. "The increased use of Merck KGaA's Erbitux and jiangsu Simcere's Endostar and the launch of Roche's Avastin will be the strongest drivers of the Chinese colorectal drug market during the next five years," ...

China-Biotics, Inc. Expands Retail Network to 60 Shining Retail Centers

...roducts are sold over-the-counter under the "Shining" brand through large distributors to more than 1,000 pharmacies and 100 supermarkets in Shanghai, jiangsu and Zhejiang. Shining is one of the most recognized brands in Shanghai. China-Biotics plans to expand its retail sales to other major cities in China ...

Aida Pharmaceuticals, Inc. Announces New Antibiotic Drug Under Development

...8 /PRNewswire-FirstCall/ -- Aida Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA) today announced that its recently-acquired research institute in the jiangsu Province, the Jiangsu Institute of Microbiology Co., Ltd or "JSIM", is developing a new wide-spectrum antibiotic, Wetimicin, in the People's Republic ...

Chindex International Announces the Opening of Wuxi United Family Healthcare Center

...nghai. The ceremony was attended by Ms. Lu Yanguang, Deputy Director of the jiangsu Entry/Exit Inspection and Quarantine Bureau, Mr. Gong Peixing, a member of ...ing significant convenience to the expatriate families in Wuxi and Southern jiangsu Province, who will gain access to quality medical care at international sta...

China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results

... was also an advanced payment in the amount of RMB13,800,000 (approximately US$1.9 million) made to a organic rice growing project in Donghai, jiangsu Province, in anticipation of a good harvest year. The advance was not utilized because the actual output of the rice was less than expected. T...

Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China

...SE: WYE ) announced today that it is investing $280 million to build a state-of-the-art nutritional manufacturing facility in Suzhou Industrial Park, jiangsu Province, China. The new facility will primarily produce infant formula milk powder and other nutritional products. When completed, the site will be o...

Toxic Algae Pose New Health Scare in China

...s Daily newspaper said. The toxic algae scare in Lake Taihu has already triggered government panic and forced residents of nearby Wuxi city in jiangsu province to turn off contaminated tapwater supplies. Scientists said that algae was still infecting Lake Taihu and had spread to Chaohu Lake in neighb...
Jiangsu in Medical Technology

Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results

...itabine, in multiple solid tumor indications including colorectal and ovarian." Access has previously announced that it has licensed ProLindac to jiangsu Aosaikang Pharmaceutical Co., Ltd. ("ASK") for the Greater China Region and to JCOM, Ltd for South Korea. Under these agreements both of these partne...

Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.

...c Biopharma Group, Ltd. (PBG), located in San Bruno California and Taizhou, jiangsu Province, People's Republic of China. The transaction was structured as an ...d China Medical City. It is headquartered in San Bruno, CA and in Taizhou, jiangsu Province at the China Medical City complex. NOTE: Other than stateme...
Jiangsu in Medical Dictionary

Potassium hydroxide

...m Hydroxide Information, history, uses and where to buy ... Pure potassium hydroxide forms white, deliquescent crystals. ... Jiangsu, China jiangsu Guangming Chemical Co., Ltd. offers potassium hydroxide . ... We supply high-quality potassium hydroxide , iron content, sulfate content, ... ...
Jiangsu in Biological News

ACS PressPac -- Sept. 17, 2008

...e Contraceptive" DOWNLOAD FULL TEXT ARTICLE http://dx.doi.org/10.1021/pr800259t CONTACT: Jiahao Sha, Ph.D. Nanjing Medical University jiangsu Province, People's Republic of China, 210029 Phone: 86-25-86862908 Fax: 86-25-86862908 Email: shajh@njmu.edu.cn ARTICLE #5 EMBARGOED...
Jiangsu in Biological Technology

Simcere Pharmaceutical Group Announces Agreement to Acquire 37.5% Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.

NANJING, China, May 26 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR ), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced an agreement to acquire a 37.5% stake in Jiangsu Yanshen Biologi...

Access Licenses ProLindac(TM) to Jiangsu Aosaikang Pharmaceutical Co., LTD., a Leading Oncology Pharmaceutical Company for Manufacturing, Development and Commercialization in the Greater China Region

Transaction Value In Excess of $25 Million; Access Gains Second Source Manufacturing And Significant Clinical Trial Support DALLAS and NANJING, PRC, June 4 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP) and Jiangsu Aosaikang Pharmaceutical Co., LTD....

MIT is pleased to announce that it has received a US$ 500,000 private placement from its Chinese partners

...e new order show the beginning of a strong commitment and a step towards a successful long-term relationship between MIT and its Chinese partners. jiangsu Hualan MIT Medical Technology (MIT CHINA) Ltd., is actively promoting and selling MIT's unique Agro-Jet(R) needle-free jet injector for animal appli...

Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in China

...y produced in China' is the corporate philosophy here which binds us directly to the ambitious objectives for development of the local economy and the jiangsu region," Raster said. At the gala opening he joined Chao Xingsong, the Managing Director of Gerresheimer Danyang, in welcoming representatives from th...

China Breaks Ground on Largest Comprehensive Stem Cell Storage and Processing Facility

...ngsu University, Shanghai Jiao Tong University and jiangsu Provincial People's Hospital. Mr. Chen Zhu,...nd abroad. About China Medical City jiangsu Province is considered the number one location for...ated over the past 5 years. The city of Taizhou in jiangsu is not only the hometown of China's President Hu J...

Access Pharmaceuticals Presents New Data on ProLindac(TM) at the 2009 AACR Annual Meeting

...bination studies later this year." Access currently has two development and commercialization partners for ProLindac. A licensing agreement with jiangsu Aosaikang Pharmaceutical Co., Ltd. ("ASK") was signed in 2008 under which ASK will manufacture, develop and commercialize ProLindac for the Greater Ch...

Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards

...ifornia, Nanjing Medical University, the China Medical City, Hua Zhong Technical University, the University of Texas Health Science Center at Houston, jiangsu People's Hospital, the No. 2 Hospital of Nanjing Medical University, and the Wu Hu City No. 2 People's Hospital in Anhui, China. These mutual cooperat...

Kiwa Bio-Tech 2nd Quarter Revenues Increase 61.7% to $3 Million, Six Month Revenues Top $5.2 Million

...rtilizers can be manufactured for farming operations. -- In June, Kiwa and jiangsu Zhongdong Fertilizer Group agreed to develop new compound bio-fertilize...Kiwa Shandong has recently adjusted its product mix in cooperation with jiangsu Zhongdong Fertilizer Group with a focus on developing new compound bio-...

Kiwa Bio-Tech Signs RMB 150 Million (US$21+ million) Fertilizer Contract

...ompany is now applying itself to adjusting its product mix, developing compound fertilizers and other new fertilizer products through cooperation with jiangsu Zhongdong Group. It is expected that before the end of 2008, part of the Agreements will be executed with newly developed products." ABOUT KIWA BIO-...

Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells

...a's Ministry of Science and Technology (MOST), the jiangsu Provincial Department for Science and Technology, ...s attended by MOST officials, the Vice Governor of jiangsu Province Mr. Zhang Taolin, and Taizhou Mayor Mr. Y...ealthcare." About the China Medical City (CMC) jiangsu Province is considered the number one location for...
Other Tags
(Date:7/30/2015)... , ... July 30, 2015 , ... ... at multinational organizations and NGO’s, according to a new survey by leading international ... that property damage and employee medical expenses represented the largest sources of financial ...
(Date:7/30/2015)... ... July 30, 2015 , ... After a three year trial designed to ... commonly known as the “bionic eye,” researchers have determined the trial to be a ... patients facing or already affected by complete vision loss as a result of Retinitis ...
(Date:7/30/2015)... ... July 30, 2015 , ... According to Chicago ... find a complete removable denture acceptable. The demand for dental implants is rising ... less expensive, immediate loading techniques will have the ability to offer the patient ...
(Date:7/30/2015)... ... 2015 , ... When trying to gain weight, many people place a lot of focus on the different types ... to be consumed. However, another key component to successful weight gain is knowing when ... this, CB-1 Weight Gainer gives three tips on when to eat to gain weight. ...
(Date:7/30/2015)... ... ... PeopleKeys, a company with over 30 years of experience in behavioral analysis, ... the newest installment in their popular DISC for the Real World series, will air ... webinar is intended for people interested in training others to use DISC behavioral analysis ...
Breaking Medicine News(10 mins):Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 2Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 3Health News:The Vision Enhancing “Bionic Eye” Deemed Safe For Long Term Use After Three Year Clinical Trial 2Health News:Chicago Implant Dentist/Implantologist Dr. Irfan Atcha Speaks to Local Dentists about Advances in Dental Implants in August. 2Health News:Chicago Implant Dentist/Implantologist Dr. Irfan Atcha Speaks to Local Dentists about Advances in Dental Implants in August. 3Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 2Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 3Health News:PeopleKeys to Air “Managing Stress: Train the Trainer” DISC Webinar 2
(Date:6/30/2015)... 2015 Genisphere announced Tom ... help further develop Genisphere,s therapeutics capabilities and portfolio. Mr. ... spent much of the last 25 years in leadership ... and Johnson & Johnson. Tom started his career in ... Corporate Finance. He graduated from Dartmouth College with a ...
(Date:6/25/2015)...  Imagine a tool specifically designed to help you ... That,s exactly what USANA,s True Health Assessment ... health program provides a personalized approached to measuring your ... lifestyle and nutrition. At the Canadian ... USANA,s THA was honored with the Industry Innovation Award. ...
(Date:6/24/2015)... Calif. , June 24, 2015  Synaptics ... of human interface solutions, today announced that Sharp ... to provide secure authentication for its latest flagship ... reached more than 200 million shipments of its ... Sharp reinforces Synaptics, strength, scalability and leadership in ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
Other Contents